Publications by authors named "Maria T Cano"

Claim this Profile
-
-Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer.
Alfredo Carrato, Roberto Pazo-Cid, Teresa Macarulla, Javier Gallego, Paula Jiménez-Fonseca, Maria Teresa Cano

NEJM Evid· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NeuroPredict: study of the predictive value of ABCB1 genetic polymorphisms and associated clinical factors in chronic chemotherapy-induced peripheral neuropathy (CIPN).
Alicia Vargas-Aliaga, María De la Haba, María José Contreras, Cristina Morales Estevez, Ignacio Porras, María Teresa Cano

Front Pharmacol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer.
María Victoria García-Ortiz, Pablo Cano-Ramírez, Marta Toledano-Fonseca, María Teresa Cano, Elizabeth Inga-Saavedra

Clin Epigenetics· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study.
Joana Vidal, Maria Concepción Fernández-Rodríguez, David Casadevall, Pilar García-Alfonso, David Páez, Maria Teresa Cano

Clin Cancer Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial).
Guillem Argilés, Nuria Mulet, Manuel Valladares-Ayerbes, José M Viéitez, Cristina Grávalos, María T Cano

Eur J Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiresponsive Cyclometalated Crown Ether Bearing a Platinum(II) Metal Center.
Miguel A Soto, Veronica Carta, Maria T Cano, Ryan J Andrews, Brian O Patrick

Inorg Chem· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug.
Emilia Alors-Perez, Ricardo Blázquez-Encinas, Sonia Alcalá, Cristina Viyuela-García, Sergio Pedraza-Arevalo, María T Cano

J Exp Clin Cancer Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour location and efficacy of first-line EGFR inhibitors in wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials.
Manuel Benavides, Eduardo Díaz-Rubio, Alfredo Carrato, Albert Abad, Carmen Guillén, María Teresa Cano

ESMO Open· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis